Truist Securities Initiates Coverage On Inventiva with Buy Rating, Announces Price Target of $13

3/19/2026
Impact: 70
Healthcare

Truist Securities has initiated coverage on Inventiva (NASDAQ: IVA) with a Buy rating. The firm has set a price target of $13 for the company's stock.

AI summary, not financial advice

Share: